Clinical trial Recruiting at 1 site Interventional Ages 4 and up

Investigating how hearing ourselves speak affects speech movements

Official title: Behavioral and Neural Characteristics of Adaptive Speech Motor Control

Run by University of Washington · NCT06164717 · Data updated 2026-11-12

This study is testing how hearing ourselves talk affects our speech movements in both regular speakers and patients with brain implants to see how it influences how we adjust our speech.

Quick facts

Study typeInterventional
Ages4 Years and up
SexAll
Enrollment507 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedDecember 11, 2023
Trial IDNCT06164717 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include native American English speakers aged 4 years and older, with no significant communication or neurological issues, and DBS patients with specific electrode implants.

Probably not a fit

Patients with severe communication or neurological problems unrelated to DBS may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the relationship between auditory feedback and speech motor control in both typical speakers and patients with Deep Brain Stimulation (DBS) implants. Participants will read various speech tasks while their speech is recorded, and some will have their brain activity monitored with an electrode cap. The study aims to determine how self-perception of speech influences future speech movements and to identify brain areas involved in speech adjustment for DBS patients. The tasks will be conducted with the DBS stimulator both ON and OFF to assess its impact.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of speech motor control, potentially leading to improved therapies for individuals with speech disorders.

How similar studies have gone: While this study investigates a novel approach, similar studies have shown promise in understanding speech motor control and the effects of auditory feedback.

Who can join: the full rules

Show full inclusion / exclusion criteria
General inclusion criteria:

* native speaker of American English
* no communication or neurological problems (except for subjects in the DBS group)
* 250-4000 Hz pure tone hearing thresholds equal to or better than 25 dB HL for children and young adults and equal to or better than 35 dB HL for older adults
* no medications that affect sensorimotor functioning (except for in the DBS group)
* adult subjects: 18 years of age or older
* typical children: 4;0 to 6;11 \[years;months\] or 10;0 to 12;11 \[years;months\])

Specific inclusion criteria for children:

\* scoring above the 20th percentile on the Peabody Picture Vocabulary Test (PPVT-5), Expressive Vocabulary Test (EVT-3), Goldman-Fristoe Test of Articulation (GFTA-3), and either Test of Early Language Development (TELD-4) or (for children age 8 or older) Clinical Evaluation of Language Fundamentals (CELF-5).

Specific inclusion criteria for DBS patients:

\* bilateral electrodes implanted in either the ventral intermediate nucleus of the thalamus (Vim; a target site for patients with essential tremor) or subthalamic nucleus (STN; a target site for patients with Parkinson's disease)

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Ludo Max, Ph.D. — University of Washington
  • Study coordinator: Ludo Max
  • Email: ludomax@uw.edu
  • Phone: 206-543-2674

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.